(EMXC) iShares MSCI Emerging - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46434G7640
EMXC: Emerging Markets, Stocks, Futures, Options, Swaps, Cash, Equivalents
The iShares MSCI Emerging Markets ex China ETF (NASDAQ:EMXC) is designed to track the performance of emerging markets, excluding China, by investing at least 80% of its assets in the component securities of the underlying index. This index is a market capitalization-weighted benchmark that encompasses large- and mid-cap stocks across 23 emerging market countries, providing a diversified exposure to these economies.
By excluding China, EMXC offers a unique investment opportunity that allows investors to tap into the growth potential of other emerging markets, such as India, South Korea, and Taiwan, among others. The funds investment strategy also includes the use of derivatives, such as futures, options, and swap contracts, to a limited extent, up to 20% of its assets, to enhance its returns or manage risk.
From a technical analysis perspective, the current price of EMXC is $60.60, indicating a bullish trend as it is above its 20-day and 50-day simple moving averages (SMA20: $59.57, SMA50: $56.88). The Average True Range (ATR) of 0.63, or 1.04%, suggests moderate volatility. Given the current technical setup, a potential forecast could be that EMXC continues its upward trajectory, potentially reaching its 52-week high of $61.92, if the emerging markets continue to attract investment flows.
Fundamentally, the Assets Under Management (AUM) of $14.279 billion indicate a significant investor interest in the ETF, underscoring its liquidity and viability as an investment option. Combining this with the technical analysis, a forecast could be made that if the AUM continues to grow and the technical indicators remain positive, EMXC could see further price appreciation, driven by both investor demand and the underlying performance of the emerging markets ex China.
Therefore, based on both technical and fundamental data, a potential investment strategy could involve maintaining or increasing exposure to EMXC, provided that the emerging markets continue to show resilience and growth, and the global economic conditions remain favorable.
Additional Sources for EMXC ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
EMXC ETF Overview
Market Cap in USD | 13,625m |
Category | Diversified Emerging Mkts |
TER | 0.25% |
IPO / Inception | 2017-07-18 |
EMXC ETF Ratings
Growth Rating | 31.4 |
Fundamental | - |
Dividend Rating | 60.0 |
Rel. Strength | -4.65 |
Analysts | - |
Fair Price Momentum | 58.26 USD |
Fair Price DCF | - |
EMXC Dividends
Dividend Yield 12m | 2.85% |
Yield on Cost 5y | 4.35% |
Annual Growth 5y | 12.54% |
Payout Consistency | 90.9% |
Payout Ratio | % |
EMXC Growth Ratios
Growth Correlation 3m | 96% |
Growth Correlation 12m | -18.5% |
Growth Correlation 5y | 41.8% |
CAGR 5y | 9.95% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 1.09 |
Alpha | -2.30 |
Beta | 0.733 |
Volatility | 14.13% |
Current Volume | 892.2k |
Average Volume 20d | 1774k |
As of July 01, 2025, the stock is trading at USD 63.14 with a total of 892,231 shares traded.
Over the past week, the price has changed by +3.85%, over one month by +6.99%, over three months by +15.96% and over the past year by +9.76%.
Neither. Based on ValueRay´s Analyses, iShares MSCI Emerging is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 31.42 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EMXC is around 58.26 USD . This means that EMXC is currently overvalued and has a potential downside of -7.73%.
iShares MSCI Emerging has no consensus analysts rating.
According to our own proprietary Forecast Model, EMXC iShares MSCI Emerging will be worth about 66.9 in July 2026. The stock is currently trading at 63.14. This means that the stock has a potential upside of +6%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 66.9 | 6% |